#lung cancer — Friday, August 21, 2026 (2 items)
| 0 | ℹ |
PARP inhibition enhances the antitumor activity of HER3-DXd in non-small cell lung cancer.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-08-21 | #lung cancer #immunotherapy #drug combination #amr #apoptosis | |
| 0 | ℹ |
The role of FGFR signaling in SCLC and NSCLC: Current insights and therapeutic perspectives.
(linkinghub.elsevier.com)
|
iScience 2026-08-21 | #lung cancer #fgfr-signaling #targeted therapy #drug resistance #oncology |